Literature DB >> 3190537

The evolution of argon laser photocoagulation scars in patients with the ocular histoplasmosis syndrome.

S S Shah1, A P Schachat, R P Murphy, S L Fine.   

Abstract

In 34 patients (35 eyes) with successfully treated histoplasmic choroidal neovascular membranes with a mean follow-up of 10.1 years, neither the neovascular membrane size nor the distance to the center of the foveal avascular zone (FAZ) affected final visual acuity. For a subgroup of 18 patients who had a two-year follow-up visit, the average chorioretinal scar expanded in area 50.1% per year for the first two years and 4.6% per year thereafter. This corresponded to a migration rate toward the FAZ of 152 micron/y for the first two years and 22 micron/y thereafter. After ten years, the average scar was 3.23 times larger than the initial treatment area and 480 micron closer to the FAZ than the initial treatment edge. Of the eight patients whose scars expanded to involve the center of the FAZ, six had final visual acuities either equal to or better than the initial visual acuities.

Entities:  

Mesh:

Year:  1988        PMID: 3190537     DOI: 10.1001/archopht.1988.01060140701038

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases.

Authors:  Joachim Wachtlin; Heinrich Heimann; Tim Behme; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-11       Impact factor: 3.117

2.  Choroidal neovascularisation and atrophy.

Authors:  J S Sunness
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

Review 3.  Laser treatment for diabetic macular edema in the 21st century.

Authors:  Pedro Romero-Aroca; Javier Reyes-Torres; Marc Baget-Bernaldiz; Cristina Blasco-Suñe
Journal:  Curr Diabetes Rev       Date:  2014-03

Review 4.  Is laser photocoagulation treatment currently useful in diabetic macular edema?

Authors:  Pere Romero-Aroca
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2015
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.